[1]陈 静,王晓玲,安 康,等.内皮脂肪酶和脂蛋白酶在冠状动脉粥样硬化发生及发展中的作用研究进展[J].陕西医学杂志,2024,(6):862-864.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.030]
　CHEN Jing,WANG Xiaoling,AN Kang,et al.Research progress on role of endothelial lipase and lipoproteinases in occurrence and development of coronary atherosclerosis[J].,2024,(6):862-864.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.030]
点击复制

内皮脂肪酶和脂蛋白酶在冠状动脉粥样硬化发生及发展中的作用研究进展
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年6期
页码:
862-864
栏目:
综 述
出版日期:
2024-06-05

文章信息/Info

Title:
Research progress on role of endothelial lipase and lipoproteinases in occurrence and development of coronary atherosclerosis
作者:
陈 静; 王晓玲; 安 康; 阮顺莉; 马 瑶
(四川大学华西医院老年医学中心/干部医疗科,四川 成都 610041)
Author(s):
CHEN Jing; WANG Xiaoling; AN Kang; RUAN Shunli; MA Yao
(Geriatrics Center/Division of Cadre Medicine,West China Hospital,Sichuan University,Chengdu 610041,China)
关键词:
冠心病;  动脉粥样硬化;  内皮脂肪酶;  脂蛋白酶;  脂代谢;  生物学特点
Keywords:
Coronary heart disease;  Atherosclerosis;  Endothelial lipase;  Lipoproteinases;  Lipid metabolism;  Biological characteristics
分类号:
R 541.4
DOI:
DOI:10.3969/j.issn.1000-7377.2024.06.030
文献标志码:
A
摘要:
冠心病是主要由冠状动脉粥样硬化导致的心肌缺血性病变。动脉壁僵硬、脂质代谢异常导致动脉内膜脂质类物质聚集、纤维组织增生和钙质沉积,斑块形成,从而影响血液运输。内皮脂肪酶(EL)是一种磷脂酶,可水解血浆高密度脂蛋白胆固醇,具有促进脂肪分解代谢的作用。脂蛋白酶(LPL)是溶解脂蛋白的关键酶,其特定的酶分子结构可水解甘油三酯,参与人体内脂蛋白代谢。因此,了解EL、LPL在冠状动脉粥样硬化发生及发展中的作用对早期防治冠心病至关重要。现对EL和LPL的结构、生物学特点以及在冠状动脉粥样硬化形成中的作用进行综述。
Abstract:
Coronary heart disease is a myocardial ischemic lesion mainly caused by coronary atherosclerosis.Arterial wall stiffness and abnormal lipid metabolism lead to lipid accumulation,fibrous tissue proliferation,calcium deposition and plaque formation in arterial intima,which affect blood transport.Endothelial lipase(EL)is a phospholipase that can hydrolyze plasma high-density lipoprotein cholesterol and promote lipid catabolism.Lipoprotein lipase(LPL)is the key enzyme to dissolve lipoproteins,and its specific enzymatic molecular structure can hydrolyze triglyceride and participate in lipoprotein metabolism in the human body.Therefore,understanding the role of EL and LPL in the occurrence and development of coronary atherosclerosis is very important for the early prevention and treatment of coronary heart disease.This article reviews the structure,biological characteristics and role of EL and LPL in the formation of coronary atherosclerosis.

参考文献/References:

[1] 吉锋,李展绒,任耀龙,等.化痰通瘀除痹方治疗冠心病合并颈动脉粥样硬化斑块痰瘀困阻证疗效研究[J].陕西中医,2022,43(9):1212-1214.
[2] 朱友义,高律萍,曹成瑛,等.高原地区汉、藏族冠状动脉与颈动脉及下肢动脉粥样硬化病变程度相关性及危险因素比较研究[J].陕西医学杂志,2023,52(4):404-407.
[3] YIN W H,WANG H Y,SUN Y,et al.Unstable plaques hide in heavily calcified coronary arteries[J].Quant Imaging Med Surg,2022,12(5):2744-2754.
[4] 陈姣,罗丹梅,孙承霞,等.扶正化浊法治疗动脉粥样硬化研究进展[J].陕西中医,2023,44(11):1653-1656.
[5] 南武娟,文申英.急性冠脉综合征大鼠外周血巨噬细胞中脂质稳态与动脉粥样硬化指数相关性研究[J].陕西医学杂志,2022,51(4):401-405.
[6] SHANG S Q,YANG Y,YANG X J,et al.Endothelial lipase promotes acute myeloid leukemia progression through metabolic reprogramming[J].Neoplasma,2022,69(4):755-763.
[7] MOON J H,KIM K,CHOI S H.Lipoprotein lipase:Is it a magic target for the treatment of hypertriglyceridemia[J].Endocrinol Metab(Seoul),2022,37(4):575-586.
[8] BARCHUK M,ANCEL P,MIKSZTOWICZ V,et al.Epicardial adipose tissue ceramides are related to lipoprotein lipase activity in coronary artery disease:Unfolding a missing link[J].Arterioscler Thromb Vasc Biol,2022,42(8):242-251.
[9] 宋星明,哈力沙?艾日肯江,迪丽胡玛尔?阿布来提,等.内皮脂肪酶作为冠心病治疗靶点的研究进展[J].基础医学与临床,2023,43(9):1443-1447.
[10] AMIN N,JOVANOVA O,ADAMS H H,et al.Exome-sequencing in a large population-based study reveals a rare Asn396Ser variant in the LIPG gene associated with depressive symptoms[J].Mol Psychiatry,2017,22(4):634-634.
[11] ZHANG J,LI K,SUN H R,et al.The heparan sulfate mimetic muparfostat aggravates steatohepatitis in obese mice due to its binding affinity to lipoprotein lipase[J].Br J Pharmacol,2023,180(14):1803-1818.
[12] SALAZAR-TORTOSA D F,PASCUAL-GAMARRA J M,LABAYEN I,et al.Interplay of physical activity and genetic variants of the endothelial lipase on cardiovascular disease risk factors[J].Pediatr Res,2022,91(4):929-936.
[13] LING P,ZHENG X,LUO S,et al.Targeting angiopoietin-like 3 in atherosclerosis:From bench to bedside[J].Diabetes Obes Metab,2021,23(9):2020-2034.
[14] DOENST T,THIELE H,HAASENRITTER J,et al.The treatment of coronary artery disease[J].Dtsch Arztebl Int,2022,119(42):716-723.
[15] DE-WINTHER M P J,BACK M,EVANS P,et al.Translational opportunities of single-cell biology in atherosclerosis[J].Eur Heart J,2023,44(14):1216-1230.
[16] KNAPP M,LUKASZUK B,LISOWSKA A,et al.Multivessel coronary artery disease complicated by diabetes mellitus has a relatively small effect on endothelial and lipoprotein lipases expression in the human atrial myocardium and coronary perivascular adipose tissue[J].Int J Mol Sci,2023,24(17):13552.
[17] NAGAO M,MIYASHITA K,MORI K,et al.Serum concentration of full-length- and carboxy-terminal fragments of endothelial lipase predicts future cardiovascular risks in patients with coronary artery disease[J].J Clin Lipidol,2019,13(5):839-846.
[18] YAN H,NIIMI M,WANG C,et al.Endothelial lipase exerts its anti-atherogenic effect through increased catabolism of β-VLDLs[J].J Atheroscler Thromb,2021,28(2):157-168.
[19] FERNANDES D N M,BATUCA J R,DELGADO A J.The role of high-density lipoprotein in the regulation of the immune response:Implications for atherosclerosis and autoimmunity[J].Immunology,2021,164(2):231-241.
[20] ADAM R C,MINTAH I J,ALEXA-BRAUN C A,et al.Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance[J].J Lipid Res,2020,61(9):1271-1286.
[21] ISHIDA T,CHOI S,KUNDU R K,et al.Endothelial lipase is a major determinant of HDL level[J].J Clin Invest,2003,111(3):347-355.
[22] PEDRO-BOTET J,CLIMENT E,BENAIGES D.Atherosclerosis and inflammation:New therapeutic approaches[J].Med Clin(Barc),2020,155(6):256-262.
[23] JIN W,SUN G S,MARCHADIER D,et al.Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase[J].Circulation research,2003,92(6):644-650.
[24] PARADIS M E,BADELLINO K O,RADER D J,et al.Endothelial lipase is associated with inflammation in humans[J].J Lipid Res,2006,47(12):2808-2813.
[25] XIE L,LI Y M.Lipoprotein lipase(LPL)polymorphism and the risk of coronary artery disease:A meta-analysis[J].Int J Environ Res Public Health,2017,14(1):84-88.
[26] KUTHIROLY S,YESODHARAN D,RADHAKRISHNAN N,et al.Lipoprotein lipase deficiency[J].Indian J Pediatr,2021,88(2):147-153.
[27] AL-SAMAWI R I,SMAISM M F.Association of the lipoprotein lipase and apolipoprotein C-Ⅱ gene polymorphisms with risk of dyslipidemia in smokers and non-smokers male[J].Indian Heart J,2022,74(1):45-50.
[28] DORAN A C.Inflammation resolution:Implications for atherosclerosis[J].Circ Res,2022,130(1):130-148.
[29] WU S A,KERSTEN S,QI L.Lipoprotein lipase and its regulators:An unfolding story[J].Trends Endocrinol Metab,2021,32(1):48-61.
[30] HITSUMOTO T,OHSAWA H,UCHI T,et al.Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis[J].Atherosclerosis,2000,153(2):391-396.

相似文献/References:

[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]汤克虎,高峻峰,任尽平.药物涂层球囊在糖尿病患者冠状动脉小血管病变治疗中的应用研究*[J].陕西医学杂志,2019,(4):432.
[3]马党捐 ,康彦智 ,柴茂林.64排128层螺旋CT冠状动脉成像在冠心病患者诊断中的价值研究*[J].陕西医学杂志,2019,(5):624.
　MA Dangjuan,KANG Yanzhi,CHAI Maolin..Value analysis of 64rows 128slice spiral CT coronary angiography in the diagnosis of patients with coronary heart disease[J].,2019,(6):624.
[4]沈 琳,马文苑.曲美他嗪联合氯吡格雷治疗冠心病心绞痛疗效及对患者心电图、血清超敏C反应蛋白和五聚素3的影响[J].陕西医学杂志,2019,(6):794.
　SHEN Lin,MA Wenyuan.ElectrocardiogramRoom,Therapeutic Effect ofTrimetazidine Combined with Clopidogrel on Angina Pectoris and its Hs-CRP[J].,2019,(6):794.
[5]杨延洁,周慧龙△.不同双抗血小板疗程对冠心病合并房颤PCI术后患者远期预后的影响*[J].陕西医学杂志,2019,(12):1653.
[6]魏 勇,梁 琪,左浩源,等.右美托咪定预处理对冠心病非心脏手术患者心肌的保护作用*[J].陕西医学杂志,2019,(12):1706.
　WEI Yong,LIANG Qi,ZUO Haoyuan,et al.Protective effect of dexmedetomidine preconditioning on myocardium in patients with coronary heart disease undergoing nonheart surgery[J].,2019,(6):1706.
[7]刘玉珊.心外膜脂肪定量及可溶性血栓调节蛋白与冠心病病变程度相关性分析[J].陕西医学杂志,2020,49(1):44.
　LIU Yushan..Correlation between the distribution of epicardial adipose tissue and soluble thrombomodulin and the severity of coronary heart disease[J].,2020,49(6):44.
[8]赵 博,王银谦,王红燕.巨噬细胞移动抑制因子与冠心病关系Meta分析[J].陕西医学杂志,2020,49(1):125.
[9]王亚平,彭春艳,朱名安Δ.冠心病合并代谢综合征患者固醇调节元件结合蛋白表达水平与脂代谢指标相关性研究*[J].陕西医学杂志,2020,49(4):419.
　WANG Yaping,PENG Chunyan,ZHU Mingan..Correlation between the levels of SREBPs and the indicators of lipid metabolism in patients with coronary heart disease complicated with metabolic syndrome[J].,2020,49(6):419.
[10]刘玉珊.老年动脉粥样硬化性心肌梗死患者血清胱抑素C水平与血管内皮细胞损伤相关性研究*[J].陕西医学杂志,2020,49(4):431.
　LIU Yushan..Relationship between serum cystatin C level and vascular endothelial cell injury in elderly patients with atherosclerotic myocardial infarction[J].,2020,49(6):431.

备注/Memo

备注/Memo:
基金项目:四川省科技计划项目(2020YFS0148); 四川省干部保健科研课题(川干研2021-113)
更新日期/Last Update: 2024-06-05